Australian/U.S. biotech Vaxxas came out of stealth mode Oct. 8, announcing a deal with Merck & Co. in which the biotech’s proprietar...

On July 24, Harvard’s Wyss Institute for Biologically Inspired Engineering announced a Cooperative Agreement worth up to $37 million from...

As this post goes live, a 2pm press briefing is starting at the AAAS Annual Meeting in Vancouver to discuss data from Waltham, MA-based ...

Takeda is in hot pursuit of Swiss biopharma Nycomed – or maybe not. After the rumorville erupted Thursday May 12 about a possible $12 billio...

Does your sex drive need a boost? We're not talking about the kind of pick-me-up that you can get from Viagra or Cialis. How about hypo...

When it comes to drug development, the Food & Drug Administration is starting to think small. Really small. Nanotechnology—the manipulat...

Congratulations to South African Trevor Immelman who held off the field at Augusta to win his first Masters' championship and claim the ...

Alkermes said today that it expects Eli Lilly to discontinue the companies' AIR Insulin collaboration: Lilly has informed Alkermes that ...

Deep breath in. Deep breath out. Nektar execs, have you found your quiet place, yet? It's been a stressful few months for Nektar employe...

It's just what Pfizer didn't need: another expensive failure. Less than six months after the much-vaunted Lipitor -replacement torce...

A ton of resources at Big Pharma are devoted to developing or licensing drug delivery technologies , for sure. But here's a publicly fun...